This content is machine translated Update 2025 Hypercholesterolemia The past 18 months have noticeably shifted the LDL-lowering landscape: An ESC/EAS-Focused Update 2025 sharpens the indication thresholds, real-world data confirm the benefit of early combinations after myocardial infarction, bempedoic...…
View Post 7 min This content is machine translated CLEAR Outcomes Study New results on bempedoic acid Statin-intolerant patients represent a difficult patient group to treat in lipid management. Now, with the CLEAR Outcomes study, it has been shown that a therapeutic option with a beneficial effect…
